Industry calls for seat at reorganised GHTF table
This article was originally published in Clinica
The group of medtech trade associations that participated in the Global Harmonization Task Force from its beginning strongly believe that industry can continue to provide valuable input to the forum and that it should have a seat at the table, Ralph Ives executive vice-president of Global Strategy and Analysis at the US medtech industry association, AdvaMed, an active player at the Global Medical Technology Alliance (GMTA), told Clinica.
You may also be interested in...
What will the fall-out of political tensions between the EU and Switzerland mean for notified bodies based in Switzerland, and for the future recognition of CE marks granted in one of the most important medtech markets in Europe?
Eighteen years of free trade threatens to come to a sudden stop, as a result of the stalemate in the market access agreement between Switzerland and the EU. Industry association Swiss Medtech is advising local medtech manufacturers to find notified bodies and authorized representatives based in the EU. However, local company SQS remains confident of its ongoing notified body role.
The last year of the run up to the full implementation of the MDR has been characterized by a flurry of new documents and measures, but industry is adamant that medtech is heading for a crisis that will impact industry and patients alike.